DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – By August 3, Congo’s outbreak of Ebola had reached 3,874 confirmed cases and 1,751 fatalities, marking it as the nation’s most extensive recorded epidemic. It ranks second globally only to the 2014 to 2016 West Africa outbreak. Congo hit 1,000 confirmed cases within 40 days of initiating its response efforts, whereas the 2018 outbreak took approximately 235 days to reach that milestone. This swift increase underscores challenges such as delayed detection, inadequate surveillance, ongoing conflict, population mobility, and the lack of approved strain-specific medical interventions.
Congo’s Ministry of Public Health announced the outbreak on May 15 after laboratory tests confirmed Bundibugyo virus in Ituri province. The WHO issued its first alert on May 5 after reports of a mysterious, deadly illness near Mongbwalu. Subsequent investigations revealed that the virus had circulated unnoticed for months before authorities identified the outbreak. Initial diagnostic tests in Bunia failed to detect Bundibugyo, as early symptoms mimicked malaria and other common febrile illnesses. This delay enabled infected individuals and contacts to move freely within communities before efforts at isolation and contact tracing could be effectively implemented.
The emergence of Bundibugyo virus also changed the available response strategies. Vaccines and antibody treatments proven effective against Zaire ebolavirus, responsible for Congo’s 2018 to 2020 epidemic, are not approved for Bundibugyo virus disease. Consequently, patients rely on rapid diagnosis, isolation, supportive medical care, strict infection prevention measures, contact tracing, and safe burial practices. The WHO has added a diagnostic test for Bundibugyo to its emergency list and initiated treatment trials, but these measures were introduced only after the virus had widely spread.
Delayed detection hampers contact tracing efforts
The outbreak has expanded from Mongbwalu to 49 health zones across Ituri, North Kivu, South Kivu, Haut-Uele, and Tshopo. Ituri reports the highest number of cases and fatalities, with Bunia, Rwampara, and Mongbwalu being among the most affected zones. WHO monitored 17,863 contacts by July 30, yet only around 75% received active follow-up in several provinces. Authorities also note that many new infections occur outside known contact chains, with surveillance teams often identifying new patients only after additional exposures have taken place.
Ongoing conflict and population displacement complicate monitoring efforts. Armed attacks have hindered response activities, restricted access, and led some health teams to suspend operations. Large groups of people continue moving through affected areas due to mining routes, trade corridors, overcrowded displacement sites, and cross-border travel. Shortages of personal protective equipment, laboratory facilities, transportation, and trained personnel further hamper the response. As of July 30, Congo had documented 151 health worker infections and 44 deaths. Frontline health staff have also halted work in some locations due to delayed or insufficient compensation.
Conflict and treatment deficiencies challenge containment efforts
Transmission occurs primarily through direct contact with blood or bodily fluids of an infected or deceased individual. Unlike influenza, it does not spread via casual proximity. Increased transmission risk is associated with clinic environments lacking proper infection control protocols and during burials involving contact with contaminated bodies. Over 60% of recent fatalities happened outside healthcare facilities, complicating efforts for safe burial and contact tracing. To address this, Congo’s health authorities, WHO, and Africa CDC have expanded laboratory capacity, treatment centers, community outreach, and border surveillance. However, these efforts still lag behind the scale and pace of new infections.
Uganda declared the end of its linked outbreak on July 28, following 42 days without a new case. The single case treated in France saw the patient recover, with no secondary transmissions reported. Congo remains the epicenter of ongoing transmission, with an early August confirmed case fatality rate of approximately 45%. The outbreak’s rapid growth stems from late detection, incomplete contact tracing, and limited access due to insecurity. The absence of approved vaccines and treatments for Bundibugyo virus removes critical tools that previously helped contain Zaire Ebola epidemics, contributing to the unprecedented speed of case increase.
}|}**#}**